If treating obesity with <scp>GLP</scp> ‐1‐based therapies protects the heart, could it also prevent cancer or improve cancer outcomes? The case for randomized trials
If treating obesity with GLP ‐1‐based therapies protects the heart, could it also prevent cancer or improve cancer outcomes? The case for randomized trials
Ioannis Ntanasis‐Stathopoulos, Anastasios Tentolouris
Citations
1 citations
Journal
Diabetes Obesity and Metabolism
Topics
Metabolism, Diabetes, and Cancer
Field-Weighted Citation Impact (FWCI)
22.24
article
If treating obesity with GLP ‐1‐based therapies protects the heart, could it also prevent cancer or improve cancer outcomes? The case for randomized trials
Ioannis Ntanasis‐Stathopoulos, Anastasios Tentolouris
article en
1 citations
Abstract
No abstract available for this paper.
Publication Tag
Diabetes Obesity and MetabolismVol. 28(3)
Institutions
Alexandra Hospital (GR), Laiko General Hospital of Athens (GR)
Ask Laika to Summarize, Analyze, and Connect papers live on the map.
Summarize Papers & Methodologies
Extract key findings, datasets, and comparative methods across publications.
Benchmark Rankings & Visual Analytics
Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.
Connect Distant Disciplines
Bridge topological clusters on the map to find hidden collaborative intersections.
If treating obesity with <scp>GLP</scp> ‐1‐based therapies protects the heart, could it also prevent cancer or improve cancer outcomes? The case for randomized trials — Ioannis Ntanasis‐Stathopoulos, Anastasios Tentolouris · Diabetes Obesity and Metabolism (2026) | TGRS Research Map | TGRS